U. Jehn

Non-infusional vs intravenous consolidation chemotherapy in eldery patients with acute myeloid leukemia : final results of th EORTC-GIMAMA AML-13 randomized phase III trial (2006)

Jehn, U., Suciu, S., Thomas, X., Lefrère, F., Muus, P., Berneman, Zwi, ...

The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921) (2003)

Suciu, S, Labar, B, Belhabri, A, Aul, C, ...

This report used the framework of a large European study to investigate the outcome of patients with and without an HLA-identical sibling donor on an intention-to-treat basis. After a common...

Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS (2001)

Suciu, S, Labar, B, Archimbaud, E, Aul, C, ...

This study investigated the feasibility of allogeneic (alloSCT) and autologous stem cell transplantation (ASCT) as postconsolidation therapy for patients with myelodysplastic syndromes (MDSs) or...

Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction/consolidation therapy, followed by a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia (1999)

Archimbaud, E., Jehn, U., Thomas, X., De Cataldo, F., Fillet, Georges, Belhabri, A., ...

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome. (1998)

DENNING, DW, MARINUS, A, COHEN, J, SPENCE, D, HERBRECHT, R, PAGANO, L, ...

Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and Idarubicin (AIDA) therapy (1997)

Coco, F. Lo, Biondi, A., Pellici, P.G., Muus, P., Willemze, R., Jehn, U., ...

Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON) (1997)

Zittoun, R., Dardenne, M., Sonneveld, P., Muus, P., Jehn, U., Schouten, H.C., ...

A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893) (1997)

Zittoun, R., Dardenne, M., Jaksic, B., Labar, B., Jehn, U., Dohner, H., ...

Enhanced pulmonary accumulation of liposomal amphotericin B (AmBisome) in acute liver transplant failure (1997)

Heinemann, V, Bosse, D, Jehn, U, Debus, A, Wachholz, K, Forst, H, ...

Autologous stem cell transplantations in elderly AML patients (1996)

Archimbaud, E., Jehn, U., De Cataldo, F., Fillet, Georges, Amadori, S., Willemze, R.

Abstract (1992)

Strohscheer, I., Kleinert, R., Westphal, C., Schüller, J., Werner, K., Anders, O., ...

Peer Reviewed

Serum pharmacology of amphotericin B applied in lipid emulsions.

Heinemann, V, Kähny, B, Jehn, U, Mühlbayer, D, Debus, A, Wachholz, K, ...

Application of amphotericin B in lipid emulsions (AmB/L) reduced membrane toxicity in vitro and decreased amphotericin B-associated toxic side effects in vivo when compared to that of amphotericin B...

Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.

Heinemann, V, Bosse, D, Jehn, U, Kähny, B, Wachholz, K, Debus, A, ...

The liposomal formulation of amphotericin B (AmBisome) greatly reduces the acute and chronic side effects of the parent drug. The present study describes the pharmacokinetic characteristics of...

Serum pharmacology of amphotericin B applied in lipid emulsions.

Heinemann, V, Kähny, B, Jehn, U, Mühlbayer, D, Debus, A, Wachholz, K, ...

Application of amphotericin B in lipid emulsions (AmB/L) reduced membrane toxicity in vitro and decreased amphotericin B-associated toxic side effects in vivo when compared to that of amphotericin B...

Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.

Heinemann, V, Bosse, D, Jehn, U, Kähny, B, Wachholz, K, Debus, A, ...

The liposomal formulation of amphotericin B (AmBisome) greatly reduces the acute and chronic side effects of the parent drug. The present study describes the pharmacokinetic characteristics of...

Prognostic value of in vitro growth pattern of colony forming cells in adult acute leukaemia.

Jehn, U., Kern, D., Wachholz, K., Hölzel, D.